InflaRx stock: buy or sell?

IFRX stock price: $2.64 0.38% At close on August 19th, 2019

Updated on:
August 19th, 2019


Shares of InflaRx appreciated a tiny 0.38% and closed at $2.64.

InflaRx N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology in the United States.

Should I buy InflaRx stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to define your own trading strategy that matches with your character as inversor. There are thousands of trading strategies for you to choose, but at we prefer those that are simple but successful.

Currently, InflaRx stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean IFRX will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is InflaRx stock a buy?

Financial institutions and banks post stock ratings everyday. At, we gathered 7 ratings published for IFRX stock in the last 30 days.

Is IFRX a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-6-5SunTrust BanksBuyHold
2019-6-5Raymond JamesOutperformMarket Perform
2019-6-5JPMorgan Chase & Co.OverweightUnderweight
2019-6-5Credit Suisse GroupOutperformUnderperform
2019-3-29Robert W. BairdOutperformOutperform
2019-2-5JPMorgan Chase & Co.OverweightTop Pick

InflaRx stock analysis

Daily outlook

InflaRx ended today at $2.64 and appreciated a tiny 0.38%.

InflaRx closed today at $2.64 and appreciated a tiny 0.38%. Since last June when IFRX stock price broke down the SMA200d line, it slid $-34.65 per share (-92.92%). IFRX marked a lower low and a lower high in the short term, defining a downward trend. Climbing above $2.79 would break this short term down trend and open possibilities for reversing this situation. On April, IFRX hit a new all time high, pushing higher than on April tops. Check different trading setups that use ATHs as triggers.

IFRX stock chart (daily)

Weekly outlook

After sliding for 4 weeks, this week InflaRx stayed constant a slightly fine 0.38%, closing at $2.64. Early August IFRX plummed a bloodcurdling -5.90% in just one week. After 4 weeks sliding, this week raised a 0.37%.

Since price and 40-weeks moving average lines crossed down early June, IFRX fell $-33.35 per share (-92.66%). Trading stocks that are under the 40-weeks (that is, 200-days) moving average mark is not recommended by many experts, as it indicates that the stock has not enough institutional support. Far behind is the all-time high InflaRx hit late April and since then the price is -95.03% below that top.

IFRX stock chart (weekly)

InflaRx stock price history

InflaRx IPO was on November 8th, 2017 at $15.19 per share1. Since then, IFRX stock sliced a -82.60%, with a yearly average of -82.60%.

1: Adjusted price after possible price splits or reverse-splits.

InflaRx stock historical price chart

IFRX stock reached all-time highs on April with a price of $53.10.

InflaRx stock price target is $34.30

How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we found 4 price targets for InflaRx stock:
IFRX stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-6-5SunTrust BanksDowngrades$55.00$5.00-90.9%
2019-6-5JPMorgan Chase & Co.Downgrades$67.00$9.00-86.6%
2019-3-29Robert W. BairdLowers Target$62.00$58.00-6.5%
2019-2-5JPMorgan Chase & Co.Reiterates$42.00$65.0054.8%
(in average)$56.50$34.30-39.0%
The price forecast for InflaRx stock is $34.30, moving in a range between $65.00 and $5.00. In average, analysts' outlook on IFRX price target is negative, downgrading the target by a -39.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

InflaRx presented slightly fine results for 2018-Q4 on March. InflaRx raised Earnings per Share (EPS) by 4.50%, beating experts consensus of $-0.44. InflaRx posted $-0.46.
IFRX earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

Compared to , last anual revenues report draw of to M dollars. When comparing vs , , profit margin (that is, the net income divided by revenues) a to .

IFRX annual Sales and Income evolution

Quarterly financial results

Reported quarter income marked $-10.28 M with a profit margin of . Profit margin stayed steady a 0.00% compared to previous quarter when profit margin was inf%. When comparing turnover to same quarter last year, InflaRx sales marked a neutral movement and stayed constant a nan%. Looking back to recent quarterly results, InflaRx posted 7 positive quarters in a row.
IFRX quarterly Sales and Income evolution

InflaRx ownership

When you are planning to invest in shares of a stock, it's worth to have a look its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For InflaRx, 38.72% of all outstanding shares are owned by its staff.

In case of InflaRx stock, 60.93% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for IFRX stock account 0.00%, no big difference from last month.

For a better understanding, the next table shows ownership data compared to other related stocks:

Market cap$62.9 M$308.9 M$246.3 M
Total shares23.8 M120.7 M49.3 M
Float shares12.8 M108.6 M45.0 M
  - Institutional holdings (%)60.9%95.2%72.8%
  - Insider holdings (%)38.7%2.5%0.2%
Shares in short selling0.0%0.0%0.0%

InflaRx summary

Monday, August 19th, 2019
Day range$2.60 - $2.68
Previous close$2.63
Session gain0.38%
Average true range$0.14
50d mov avg$3.05
100d mov avg$21.75
200d mov avg$27.86
Daily patternlb06a
Weekly pattern lb06a

InflaRx performance

To better understand InflaRx performance you must becnhmark its gains with other related stocks in same sector or industry. We chose PDL BioPharma and Pieris Pharmaceuticals as the bechmarking frame for InflaRx stock.
PDLIPDL BioPharma-14.95%-23.12%9.87%
PIRSPieris Pharmaceut...39.28%62.87%-1.77%

InflaRx competitors

Creating a list of competitors for InflaRx it's tough. We selected 2 public companies that are related to and can be considered as competitors of InflaRx: